[Anaphylactic shock following multiple injection of a multienzyme compound (author's transl)].
An anaphylactic shock after multiple injections of the multienzyme compound Neoblastine with the clinical signs of unconsciousness, tachycardia and marked depression of vascular system is reported. Specific antibodies (double diffusion method; 1:32) and an increasing eosinophilia of the peripheral blood up to 36 rel. % have been demonstrated. It must be warned of the application of this compound, the indication of which is extremely doubtful.
D000328:Adult; D000707:Anaphylaxis / Q000139:chemically induced*; D000906:Antibodies / Q000032:analysis; D001794:Blood Pressure; D004338:Drug Combinations; D005260:Female; D005334:Fever; D006801:Humans; D005779:Immunodiffusion; D007273:Injections, Intramuscular; D008049:Lipase / Q000009:adverse effects / Q000627:therapeutic use; D008995:Monoamine Oxidase / Q000009:adverse effects / Q000627:therapeutic use; D009097:Multienzyme Complexes / Q000009:adverse effects* / Q000627:therapeutic use; D010088:Oxidoreductases / Q000009:adverse effects / Q000627:therapeutic use; D013272:Stomach Diseases / Q000188:drug therapy; D013610:Tachycardia / Q000139:chemically induced; D014474:Unconsciousness / Q000139:chemically induced
D000906:Antibodies; D004338:Drug Combinations; D009097:Multienzyme Complexes; D010088:Oxidoreductases; D008995:Monoamine Oxidase; D008049:Lipase
Anaphylaktischer Schock nach Injektion eines Multienzympräparats